These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 2525981)

  • 41. Plasma pharmacokinetics of cinmetacin following oral administration in healthy volunteers.
    Danesi R; Ducci M; Acerbi D; Del Tacca M
    Arzneimittelforschung; 1988 Jan; 38(1):129-31. PubMed ID: 3259136
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effects of etodolac on human chondrocytes cultivated in three dimensional culture.
    Henrotin Y; Bassleer C; Reginster JY; Franchimont P
    Clin Rheumatol; 1989 Mar; 8 Suppl 1():36-42. PubMed ID: 2545406
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Etodolac--a new non-steroidal agent].
    Bliddal H; Kryger P
    Ugeskr Laeger; 1990 Sep; 152(36):2587-8. PubMed ID: 2144929
    [No Abstract]   [Full Text] [Related]  

  • 44. Pharmacokinetics of rofecoxib in children with sickle cell hemoglobinopathy.
    Prescilla RP; Frattarelli DA; Haritos D; Aranda JV; Edwards DJ
    J Pediatr Hematol Oncol; 2004 Oct; 26(10):661-4. PubMed ID: 15454838
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The pharmacokinetics of etodolac in serum and synovial fluid of patients with arthritis.
    Kraml M; Hicks DR; McKean M; Panagides J; Furst D
    Clin Pharmacol Ther; 1988 May; 43(5):571-6. PubMed ID: 2966693
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Single-dose pharmacokinetics of nateglinide in subjects with hepatic cirrhosis.
    Choudhury S; Hirschberg Y; Filipek R; Lasseter K; McLeod JF
    J Clin Pharmacol; 2000 Jun; 40(6):634-40. PubMed ID: 10868314
    [TBL] [Abstract][Full Text] [Related]  

  • 47. An open-label study to determine the pharmacokinetics and safety of migalastat HCl in subjects with impaired renal function and healthy subjects with normal renal function.
    Johnson FK; Mudd PN; DiMino T; Vosk J; Sitaraman S; Boudes P; France N; Barlow C
    Clin Pharmacol Drug Dev; 2015 Jul; 4(4):256-61. PubMed ID: 27136905
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A series of pharmacokinetic studies of ceftaroline fosamil in select populations: normal subjects, healthy elderly subjects, and subjects with renal impairment or end-stage renal disease requiring hemodialysis.
    Riccobene T; Jakate A; Rank D
    J Clin Pharmacol; 2014 Jul; 54(7):742-52. PubMed ID: 24431097
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Therapeutic choices for rheumatic disorders.
    Hughes G
    Gerontology; 1988; 34 Suppl 1():27-32. PubMed ID: 2977119
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Etodolac therapy for osteoarthritis: a double-blind, placebo-controlled trial.
    Williams PI; Hosie J; Scott DL
    Curr Med Res Opin; 1989; 11(7):463-70. PubMed ID: 2528440
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Pharmacokinetic modeling and simulation of etodolac following single oral administration in dogs.
    Baek IH
    Xenobiotica; 2019 Aug; 49(8):981-986. PubMed ID: 30216103
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Serum and tissue fluid norfloxacin concentrations after oral administration of the drug to healthy dogs.
    Walker RD; Stein GE; Budsberg SC; Rosser EJ; MacDonald KH
    Am J Vet Res; 1989 Jan; 50(1):154-7. PubMed ID: 2919820
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Quantification of Etodolac in Human Plasma for Pharmacokinetics and Bioequivalence Studies in 27 Korean Subjects.
    Song ID; Kang JS; Kim HJ; Kim SM; Zhao DX; Kim SH; Chun MY; Lee KH
    Drug Metab Lett; 2017; 10(4):286-294. PubMed ID: 28093968
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Pharmacokinetics of cefadroxil in normal subjects and in patients with renal insufficiency.
    Humbert G; Leroy A; Fillastre JP; Godin M
    Chemotherapy; 1979; 25(4):189-95. PubMed ID: 456077
    [TBL] [Abstract][Full Text] [Related]  

  • 55. An endoscopic evaluation of the effects of etodolac and diclofenac on the gastric and duodenal mucosa.
    van Eeden A; Schotborgh RH; Tytgat GN
    Clin Ther; 1990; 12(6):496-502. PubMed ID: 2149673
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Pharmacokinetics and tolerability of sumatriptan after single-dose administration of a fixed-dose combination tablet of sumatriptan/naproxen sodium 85/500 mg followed two hours later by subcutaneous sumatriptan 4- or 6-mg injection: a randomized, open-label, three-period crossover study in healthy volunteers.
    Berges A; Walls C; Lener SE; McDonald SA
    Clin Ther; 2010 Jun; 32(6):1165-77. PubMed ID: 20637969
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Gastrointestinal blood loss in arthritic patients receiving chronic dosing with etodolac and piroxicam.
    Jallad NS; Sanda M; Salom IL; Perdomo CS; Garg DC; Mullane JF; Weidler DJ
    Am J Med Sci; 1986 Nov; 292(5):272-6. PubMed ID: 2946224
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Pharmacokinetics of nateglinide in renally impaired diabetic patients.
    Devineni D; Walter YH; Smith HT; Lee JS; Prasad P; McLeod JF
    J Clin Pharmacol; 2003 Feb; 43(2):163-70. PubMed ID: 12616669
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Influence of age on the pharmacokinetics of naftidrofuryl after single oral administration in elderly versus young healthy volunteers.
    Hulot T; Gamand S; Dupain T; Ahtoy P; Bromet M
    Arzneimittelforschung; 1998 Sep; 48(9):900-4. PubMed ID: 9793615
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Clinical pharmacokinetics of nimesulide.
    Bernareggi A
    Clin Pharmacokinet; 1998 Oct; 35(4):247-74. PubMed ID: 9812177
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.